High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.

[1]  L. Degenhardt,et al.  Estimating The Level of HIV Prevention Coverage, Knowledge and Protective Behavior Among Injecting Drug Users: What Does The 2008 UNGASS Reporting Round Tell Us? , 2009, Journal of acquired immune deficiency syndromes.

[2]  Mohsen Malekinejad,et al.  Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: A Systematic Review , 2008, AIDS and Behavior.

[3]  D. D. Des Jarlais,et al.  HIV risk behaviors among female IDUs in developing and transitional countries , 2007, BMC public health.

[4]  D. Heckathorn.  6. Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment , 2007 .

[5]  C. Parry,et al.  Review of injection drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania , 2006 .

[6]  Matthew J. Salganik,et al.  5. Sampling and Estimation in Hidden Populations Using Respondent-Driven Sampling , 2004 .

[7]  Douglas D. Heckathorn,et al.  Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hi , 2002 .

[8]  P. Reuter.  World drug report , 1998 .

[9]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[10]  T. Schwarz,et al.  Hepatitis C and arboviral antibodies in the island populations of mauritius and Rodrigues , 1994, Journal of medical virology.

[11]  Cyprian Wejnert,et al.  RESPONDENT-DRIVEN SAMPLING FOR ONLINE RESEARCH , 2007 .

[12]  Katrin Baumgartner,et al.  World Drug Report 2000 , 2000 .